Retinoblastoma natural history, complications, and prognosis

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma natural history, complications, and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma natural history, complications, and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma natural history, complications, and prognosis

CDC on Retinoblastoma natural history, complications, and prognosis

Retinoblastoma natural history, complications, and prognosis in the news

Blogs on Retinoblastoma natural history, complications, and prognosis

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma natural history, complications, and prognosis

Overview

Retinoblastoma is a cancer of the retina. Development of this tumor is initiated by mutations[1] that inactivate both copies of the RB1 gene, which codes for the retinoblastoma protein.[2]

Prognosis

The prognosis of retinoblastoma depends on the following:

  • Whether or not the tumor can be removed by surgery.
  • The stage of the cancer: the size of the tumor, whether the cancer has spread
  • The child’s general health

Reese-Ellsworth classification(REC) for Retinoblastoma:

The Reese-Ellsworh classification was developed in the 1960s by Dr.Algernon Reese and Dr.Robert Ellsworth, two prominent New York doctors specialising in retinoblastoma. The system was designed to predict outcome from treatment with External beam radiotherapy(EBRT), used internationally as the primary eye salvage treatment until intoduction of chemotherapy in the 1980s.

The REC is rarely used today as chemotherapy has superseded radiotherapy as the favoured treatment for eye salvage.

Group 1: Very favourable for maintenance of sight

A: Solitary tumor, smaller than 4 disc diameters(DD) at or behind the equator

B: Multiple tumors, none larger than 4 DD, all at or behind the equator

Group 2: Favourable for maintenance of sight

A: Solitary tumor, 4 to 10 DD at or behind the equator

B: Multiple tumors, 4 to 10 DD behind the equator

Group 3: possible for maintenance of sight

A: Any lesion anterior to the equator

B: Solitary tumor, larger than 10 DD behind the equator

Group 4: unfavourable for maintenance of sight

A: Multiple tumors, some larger than 10 DD

B: Any lesion extending anteriorly to the ora serrata

Group 5: very unfavourable for maintenance of sight

A: Massive tumors involving more than one half of the retina

B: Vitreous seeding

Essen classification:


Survival:

The survival for children diagnosed with retinoblastoma in the period 1975-94 was quite favourable, with more than 93% alive at five years after diagnosis and males and females had similar 5 year survival rates for the period 1975-94 and black children had slightly lower survival rates than white children.(89% versus 94%)[3]

Possible complications

  • Local spread of tumor.
  • Development of other tumors.
  • Cataract from radiotherapy.
  • Failure of tooth eruption after radiotherapy.
  • Bony deformities

References

  1. Knudson A (1971). "Mutation and cancer: statistical study of retinoblastoma". Proc Natl Acad Sci U S A. 68 (4): 820–3. PMID 5279gadgqetqer523 Check |pmid= value (help).
  2. Friend S, Bernards R, Rogelj S, Weinberg R, Rapaport J, Albert D, Dryja T. "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma". Nature. 323 (6089): 643–6. PMID 2877398.
  3. http://seer.cancer.gov/publications/childhood/retinoblastoma.pdf

See also


Template:Nervous tissue tumors


Template:WikiDoc Sources